rs2239595

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004525.3(LRP2):​c.5098+70C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.147 in 1,526,420 control chromosomes in the GnomAD database, including 20,719 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1927 hom., cov: 32)
Exomes 𝑓: 0.15 ( 18792 hom. )

Consequence

LRP2
NM_004525.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.979

Publications

12 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 2-169233341-G-A is Benign according to our data. Variant chr2-169233341-G-A is described in ClinVar as Benign. ClinVar VariationId is 1257304.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.359 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP2NM_004525.3 linkc.5098+70C>T intron_variant Intron 30 of 78 ENST00000649046.1 NP_004516.2 P98164Q7Z5C0Q7Z5C1
LRP2XM_011511183.4 linkc.5098+70C>T intron_variant Intron 30 of 77 XP_011509485.1
LRP2XM_047444340.1 linkc.4174+70C>T intron_variant Intron 30 of 78 XP_047300296.1
LRP2XM_011511184.3 linkc.2809+70C>T intron_variant Intron 15 of 63 XP_011509486.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP2ENST00000649046.1 linkc.5098+70C>T intron_variant Intron 30 of 78 NM_004525.3 ENSP00000496870.1 P98164

Frequencies

GnomAD3 genomes
AF:
0.131
AC:
19964
AN:
152108
Hom.:
1929
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0321
Gnomad AMI
AF:
0.116
Gnomad AMR
AF:
0.268
Gnomad ASJ
AF:
0.184
Gnomad EAS
AF:
0.372
Gnomad SAS
AF:
0.257
Gnomad FIN
AF:
0.111
Gnomad MID
AF:
0.199
Gnomad NFE
AF:
0.133
Gnomad OTH
AF:
0.158
GnomAD4 exome
AF:
0.148
AC:
203685
AN:
1374194
Hom.:
18792
AF XY:
0.151
AC XY:
103760
AN XY:
688592
show subpopulations
African (AFR)
AF:
0.0280
AC:
886
AN:
31642
American (AMR)
AF:
0.377
AC:
16761
AN:
44408
Ashkenazi Jewish (ASJ)
AF:
0.192
AC:
4910
AN:
25532
East Asian (EAS)
AF:
0.346
AC:
13596
AN:
39258
South Asian (SAS)
AF:
0.237
AC:
19974
AN:
84228
European-Finnish (FIN)
AF:
0.120
AC:
6382
AN:
53290
Middle Eastern (MID)
AF:
0.197
AC:
1100
AN:
5594
European-Non Finnish (NFE)
AF:
0.127
AC:
131124
AN:
1032736
Other (OTH)
AF:
0.156
AC:
8952
AN:
57506
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
9000
18000
26999
35999
44999
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4732
9464
14196
18928
23660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.131
AC:
19961
AN:
152226
Hom.:
1927
Cov.:
32
AF XY:
0.136
AC XY:
10093
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.0321
AC:
1333
AN:
41564
American (AMR)
AF:
0.268
AC:
4100
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.184
AC:
639
AN:
3472
East Asian (EAS)
AF:
0.373
AC:
1933
AN:
5180
South Asian (SAS)
AF:
0.255
AC:
1227
AN:
4814
European-Finnish (FIN)
AF:
0.111
AC:
1172
AN:
10600
Middle Eastern (MID)
AF:
0.187
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
0.133
AC:
9060
AN:
67988
Other (OTH)
AF:
0.159
AC:
336
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
853
1706
2560
3413
4266
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
222
444
666
888
1110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.139
Hom.:
5146
Bravo
AF:
0.139
Asia WGS
AF:
0.278
AC:
965
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
6.2
DANN
Benign
0.73
PhyloP100
-0.98
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2239595; hg19: chr2-170089851; COSMIC: COSV55569878; API